Tarsons Products Limited has informed the Exchange about Credit Rating- Revision

New credit facilityCredit & Debt View source PDF Explain this filing

TARSONS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹371.65

prior close

₹376.95

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+0.4% vs market

Medical Equipment & Supplies peers, median of 9sector-0.8%+1.5% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 1.5 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.6

10m

-1.4

15m

-1.4

30m

-1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6+0.3+0.4-0.8+1.5

Next day

+3.6+0.8+2.8+0.4+3.2

+4.5+2.7+1.8+4.1+0.4

+3.1+2.7+0.4+3.9-0.7

+3.2+3.2-0.0+2.5+0.7

+6.6+4.1+2.4+4.9+1.7

+4.7+4.0+0.7+7.9-3.1

15d

+3.3+4.4-1.1+9.8-6.5

+2.8+5.4-2.6+6.2-3.4

-12.5+1.5-14.1+11.9-24.4

-17.3+3.3-20.7-6.1-11.3

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 9Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CARE Ratings has reaffirmed the credit ratings for Tarsons Products Limited's bank loan facilities on 20th June 2025. The long-term bank facilities have been reaffirmed at CARE A; Stable, with the total amount enhanced from ₹496.02 crores to ₹516.02 crores. Long-term/short-term facilities of ₹25 crores were reaffirmed at CARE A; Stable / CARE A1, and short-term facilities of ₹39 crores were reaffirmed at CARE A1. CARE A indicates adequate safety for debt servicing, and CARE A1 is the highest short-term rating, reflecting strong financial health.

Likely market impact

The rating reaffirmation signals continued creditworthiness and stable financial health, which is positive for shareholders. The ₹20 crore increase in long-term bank facility limit suggests improved access to credit, supporting future growth or working capital needs.